What drugs does SCILEX PHARMS make?

SCILEX PHARMS has 3 FDA-approved drugs including ELYXYB, GLOPERBA, ZTLIDO.

What therapeutic areas does SCILEX PHARMS focus on?

SCILEX PHARMS focuses primarily on Immunology.

← Back

Data updated: Mar 29, 2026

SCILEX PHARMS

Immunology

Pharma

SCILEX PHARMS is a pharmaceutical company focused on Immunology. Key products include ELYXYB.

2018

Since

Drugs

Trials

Approved (2yr)

Key Drugs

ELYXYB

celecoxib

Immunology

COX-2 6 indications · 2020

GLOPERBA

colchicine

beta-tubulin 1 indications · 2019

ZTLIDO

lidocaine

Sodium Channels 1 indications · 2018

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

SEC Filings ProEarly access

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 100%

1 drugs

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

Johnson & Johnson big-pharma

Immunology

SCILEX PHARMS

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (3)

Active (3)

Discontinued (0)

Company Info

SCILEX PHARMS

Set Alert

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (3)

Active (3)

Discontinued (0)

Company Info